NCT07588971 Natural History and Prognosis of Pediatric Epilepsies With Different Etiology
| NCT ID | NCT07588971 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
| Condition | Pediatric Epilepsies |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,300 participants |
| Start Date | 2021-10-26 |
| Primary Completion | 2027-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,300 participants in total. It began in 2021-10-26 with a primary completion date of 2027-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Epilepsy is one of the most common neurological diseases in Italy, affecting about 500,000 people. Pediatric age represents one of the most affected groups with a consequent significant impact on the quality of life of the families involved. The study aims to monitor the cognitive functions of patients followed at our center in order to determine the main types of pathways and highlight their determinants. The ultimate goal is to define what are the main clinical and instrumental predictors of cognitive function and its variation over time.
Eligibility Criteria
Inclusion Criteria: * Patients seen at the Children's Neuropsychiatry of the Fondazione Policlinico Gemelli IRCCS (UOS Diagnosis and Treatment of Drug-Resistant Epilepsies, Day Hospital or inpatient setting at the Department of Children's Neuropsychiatry) with onset of first seizure between the ages of 0 and 18 years and subsequent diagnostic confirmation of epilepsy (2 or more unprovoked seizures at least 24 hours apart or definite epilepsy syndrome, with diagnostic confirmation by the child neuropsychiatrist). * Patients already followed at Child Neuropsychiatry with a diagnosis of epilepsy with age of onset between 0 and 18 years. * Patients referred to our Center during follow-up with a diagnosis of epilepsy with age of onset between 0 and 18 years. Exclusion Criteria: * Patients with unconfirmed diagnosis of epilepsy after the first critical episode. * Patients from other Centers, for whom the history, clinical and instrumental data are not sufficiently detailed and in accordance with the methodologies followed at our Center. * Patients with follow-up \< 2 years. * Patients for whom study consent is not provided.
Contact & Investigator
Domenica Immacolata Battaglia, MD
✉ domenicaimmacolata.battaglia@policlinicogemelli.it📞 +39 0630159222
Domenica Immacolata Battaglia
PRINCIPAL INVESTIGATOR
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Frequently Asked Questions
Who can join the NCT07588971 clinical trial?
This trial is open to participants of all sexes, up to 18 Years, studying Pediatric Epilepsies. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07588971 currently recruiting?
Yes, NCT07588971 is actively recruiting participants. Contact the research team at domenicaimmacolata.battaglia@policlinicogemelli.it for enrollment information.
Where is the NCT07588971 trial being conducted?
This trial is being conducted at Rome, Italy.
Who is sponsoring the NCT07588971 clinical trial?
NCT07588971 is sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS. The principal investigator is Domenica Immacolata Battaglia at Fondazione Policlinico Universitario Agostino Gemelli IRCCS. The trial plans to enroll 2,300 participants.